IDEX Files 8-K on Financial Results & Regulation FD Disclosure

Ticker: IEX · Form: 8-K · Filed: Feb 7, 2024 · CIK: 832101

Idex Corp /De/ 8-K Filing Summary
FieldDetail
CompanyIdex Corp /De/ (IEX)
Form Type8-K
Filed DateFeb 7, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: earnings, financial-results, regulation-fd, corporate-filing

TL;DR

**IDEX just dropped an 8-K about financial results, expect news soon!**

AI Summary

IDEX Corporation filed an 8-K on February 7, 2024, reporting an event that occurred on February 6, 2024, related to 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure'. This filing indicates that IDEX is likely providing an update on its financial performance, possibly an earnings release or a significant financial event. For investors, this matters because it provides crucial, timely information about the company's health and future prospects, which can directly impact stock price.

Why It Matters

This filing signals that IDEX Corporation is releasing important financial information, which can influence investor sentiment and the company's stock valuation. Investors need to review the full details to understand the impact on their holdings.

Risk Assessment

Risk Level: medium — The filing itself is administrative, but the underlying financial information it refers to could contain positive or negative news, creating market volatility.

Analyst Insight

A smart investor would look for the full financial results or press release that this 8-K is likely referencing, as the 'Results of Operations and Financial Condition' item indicates significant financial news is being disclosed.

Key Players & Entities

  • IDEX CORP /DE/ (company) — the registrant filing the 8-K
  • February 6, 2024 (date) — date of the earliest event reported
  • February 7, 2024 (date) — date the 8-K was filed
  • New York Stock Exchange (company) — exchange where IDEX Common Stock (IEX) is registered
  • IEX (company) — trading symbol for IDEX Common Stock

Forward-Looking Statements

  • IDEX Corporation will release its full financial results for the period ending December 31, 2023, shortly after this 8-K filing. (IDEX Corporation) — high confidence, target: 2024-02-15
  • The 'Regulation FD Disclosure' item suggests IDEX may have held an earnings call or investor presentation on February 6, 2024. (IDEX Corporation) — medium confidence, target: 2024-02-06

FAQ

What is the primary purpose of this 8-K filing by IDEX Corporation?

The primary purpose of this 8-K filing by IDEX Corporation is to report an event related to 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' that occurred on February 6, 2024.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 6, 2024.

What is the trading symbol and exchange for IDEX Corporation's Common Stock?

IDEX Corporation's Common Stock trades under the symbol IEX on the New York Stock Exchange.

Is IDEX Corporation considered an 'emerging growth company' according to this filing?

No, the filing indicates with a '☐' (unchecked box) that IDEX Corporation is not an 'emerging growth company' as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

What is IDEX Corporation's state of incorporation and business address?

IDEX Corporation's state of incorporation is Delaware, and its business address is 3100 Sanders Road, Suite 301, Northbrook, Illinois 60062.

Filing Stats: 1,136 words · 5 min read · ~4 pages · Grade level 15.2 · Accepted 2024-02-07 09:30:59

Filing Documents

02 – Results of Operations and Financial Condition

Item 2.02 – Results of Operations and Financial Condition. On February 6, 2024 , IDEX Corporation (the "Company") issued a press release announcing financial results for the period ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report furnished pursuant to Item 2.02 shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. This information shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.

01 – Regulation FD Disclosure

Item 7.01 – Regulation FD Disclosure. Q4 2023 Presentation Slides Presentation slides discussing IDEX Corporation's quarterly operating results are attached to this Current Report on Form 8-K as Exhibit 99.2 and are incorporated herein by reference. The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand the future prospects of a company and make informed investment decisions. This Current Report and the Exhibits hereto may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company's first quarter 2024 and full year 2024 outlook including expected organic sales projections, expected earnings per share and adjusted earnings per share, and the assumptions underlying these expectations, anticipated future acquisition behavior, anticipated trends in end markets and the anticipated benefits of the Company's recent acquisitions, and are indicated by words or phrases such as "anticipates," "estimates," "plans," "guidance," "expects," "projects," "forecasts," "should," "could," "will," "believes," "intends" and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets and adverse developments affecting the financial services industry; pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries, all of which could have a material impact on order rates and the Company's results; the impact of health epidem

01 – Financial Statements and Exhibits

Item 9.01 – Financial Statements and Exhibits. (a) Exhibits 99.1 Press release dated February 6, 2024 announcing IDEX Corporation's quarterly operating results 99.2 Presentation slides of IDEX Corporation's quarterly operating results SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEX CORPORATION By: /s/ ABHISHEK KHANDELWAL Abhishek Khandelwal Senior Vice President and Chief Financial Officer February 7, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.